Take off with Alnylam Pharmaceuticals Inc. (ALNY): Get ready for trading

Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) stock fell -8.78% on Thursday to $193.06 against a previous-day closing price of $211.65. With 2.11 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.54 million shares. The 52-week range on ALNY shows that it touched its highest point at $242.97 and its lowest point at $178.64 during that stretch. It currently has a 1-year price target of $246.47. Beta for the stock currently stands at 0.44.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ALNY was down-trending over the past week, with a drop of -4.16%, but this was up by 6.46% over a month. Three-month performance dropped to -2.27% while six-month performance rose 3.19%. The stock lost -8.93% in the past year, while it has lost -18.76% so far this year. A look at the trailing 12-month EPS for ALNY yields -8.62 with Next year EPS estimates of -2.38. For the next quarter, that number is -1.43. This implies an EPS growth rate of -29.10% for this year and 62.50% for next year.

Float and Shares Shorts:

At present, 124.66 million ALNY shares are outstanding with a float of 124.53 million shares on hand for trading. On Aug 30, 2023, short shares totaled 5.3 million, which was 4.24% higher than short shares on Jul 30, 2023. In addition to Dr. Yvonne L. Greenstreet M.B.A., MBA, MBChB as the firm’s CEO & Director, Dr. Akshay K. Vaishnaw M.D., Ph.D. serves as its Pres.

Institutional Ownership:

Through their ownership of 97.71% of ALNY’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 69.13% of ALNY, in contrast to 27.54% held by mutual funds. Shares owned by individuals account for 17.82%. As the largest shareholder in ALNY with 13.25% of the stake, Capital Research & Management Co holds 16,497,551 shares worth 16,497,551. A second-largest stockholder of ALNY, Fidelity Management & Research Co, holds 12,072,199 shares, controlling over 9.70% of the firm’s shares. The Vanguard Group, Inc. is the third largest shareholder in ALNY, holding 11,351,829 shares or 9.12% stake. With a 6.33% stake in ALNY, the American Funds Growth Fund of Ame is the largest stakeholder. A total of 7,886,596 shares are owned by the mutual fund manager. The Vanguard Health Care Fund, which owns about 3.79% of ALNY stock, is the second-largest Mutual Fund holder. It holds 4,718,518 shares valued at 922.0 million. Vanguard Total Stock Market ETF holds 3.11% of the stake in ALNY, owning 3,870,018 shares worth 756.2 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ALNY since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With ALNY analysts setting a high price target of $405.00 and a low target of $141.00, the average target price over the next 12 months is $247.08. Based on these targets, ALNY could surge 109.78% to reach the target high and fall by -26.97% to reach the target low. Reaching the average price target will result in a growth of 27.98% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Summary of Insider Activity:

Insiders traded ALNY stock several times over the past three months with 9 Buys and 34 Sells. In these transactions, 55,613 shares were bought while 25,649 shares were sold. The number of buy transactions has increased to 29 while that of sell transactions has risen to 87 over the past year. The total number of shares bought during that period was 163,097 while 132,543 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *